The Calcium-sensing Receptor in Physiology and in Calcitropic and Noncalcitropic Diseases
Overview
Affiliations
The Ca-sensing receptor (CaSR) is a dimeric family C G protein-coupled receptor that is expressed in calcitropic tissues such as the parathyroid glands and the kidneys and signals via G proteins and β-arrestin. The CaSR has a pivotal role in bone and mineral metabolism, as it regulates parathyroid hormone secretion, urinary Ca excretion, skeletal development and lactation. The importance of the CaSR for these calcitropic processes is highlighted by loss-of-function and gain-of-function CaSR mutations that cause familial hypocalciuric hypercalcaemia and autosomal dominant hypocalcaemia, respectively, and also by the fact that alterations in parathyroid CaSR expression contribute to the pathogenesis of primary and secondary hyperparathyroidism. Moreover, the CaSR is an established therapeutic target for hyperparathyroid disorders. The CaSR is also expressed in organs not involved in Ca homeostasis: it has noncalcitropic roles in lung and neuronal development, vascular tone, gastrointestinal nutrient sensing, wound healing and secretion of insulin and enteroendocrine hormones. Furthermore, the abnormal expression or function of the CaSR is implicated in cardiovascular and neurological diseases, as well as in asthma, and the CaSR is reported to protect against colorectal cancer and neuroblastoma but increase the malignant potential of prostate and breast cancers.
He T, Li X, Li G, Wang W, Fu H, Gao Z Front Endocrinol (Lausanne). 2025; 16:1503128.
PMID: 40070587 PMC: 11893564. DOI: 10.3389/fendo.2025.1503128.
The Use of Biologics for Targeting GPCRs in Metastatic Cancers.
McBrien C, OConnell D BioTech (Basel). 2025; 14(1).
PMID: 39982274 PMC: 11843943. DOI: 10.3390/biotech14010007.
Role of the calcium-sensing receptor in regulating vascular function.
Albert A, Greenberg H J Cell Commun Signal. 2025; 19(1):e70004.
PMID: 39912052 PMC: 11798592. DOI: 10.1002/ccs3.70004.
Hypoparathyroidism: diagnosis, management and emerging therapies.
Khan S, Khan A Nat Rev Endocrinol. 2025; .
PMID: 39905273 DOI: 10.1038/s41574-024-01075-8.
The Effect of Omeprazole on Urinary Magnesium Excretion in Children with Peptic Diseases.
Famouri F, Tavahen N, Gholami H, Yazdi M, Heidari-Beni M, Momenzadeh M J Res Pharm Pract. 2025; 13(2):53-57.
PMID: 39830949 PMC: 11737616. DOI: 10.4103/jrpp.jrpp_35_24.